The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms announced that approval has been received from an independent review board, for human pilot study #3 (the "Study"), ...

Eli Lilly has announced a $4.5bn investment to establish the Lilly Medicine Foundry for drug production and manufacturing ...

Muscle-sparing is particularly important in patients with heart failure as it is associated with higher mortality.